SAN ANTONIO – Next-generation HER2-targeting drugs are inching toward the market to further expand use of this treatment class in earlier lines of ...
News
- SABCS Studies Highlight Novel HER2 Therapies in Frontline Setting, HER2-Low, Brain Metastases
- Intensity Therapeutics reports positive results of INT230-6 in breast cancer - Yahoo Finance
... San Antonio Breast Cancer Symposium being held December 10-13 in San Antonio, Texas. The INVINCIBLE-4 Study is to determine the clinical activity ...
- High-risk breast cancer patients see improved outcomes with anthracyclines
... San Antonio Breast Cancer Symposium (SABCS), held December 10–13, 2024. "HR-positive, HER2-negative is the most common type of breast cancer in ...
- Next-Generation Drugs Show Benefits of More Specific PI3Kα Inhibition at SABCS
Filed under. Precision Oncology · San Antonio Breast Cancer Symposium · Breast Cancer · HER2 Biomarkers · phase I clinical study · phase II clinical ...
- Ladenburg Thalmann to Host Scientific Showcase December 18, 2024 About Rare Disease ...
... San Antonio Breast Cancer Symposium (SABCS), wh. 12/9/24 10:00:00 AM ET. $JAGX. Biotechnology: Pharmaceutical Preparations. Health Care. $JAGX.